New Zealand’s PHARMAC Flip Flops On Decision To Fund Roche, Abbott Glucose Meters In Favor Of Sole Supplier
This article was originally published in PharmAsia News
Executive Summary
Sole-supplier contracts continue to cause controversy in New Zealand, even as PHARMAC defends the practice.